Table 3.
HR with 95% CI for complete response in locally advanced basal cell carcinoma associated with patient and tumour characteristics (n = 44).
| Characteristic | HR with 95% CI univariable analysis | P value | HR with 95% CI multivariable analysis | P value |
|---|---|---|---|---|
| Age (per year)a | 0.99 (0.96–1.03) | 0.85 | ||
| Sex | ||||
| Male | 1.00 | |||
| Female | 1.78 (0.63–5.07) | 0.28 | ||
| Tumour size (per cm)b | 0.91 (0.79–1.06) | 0.24 | 0.77 (0.62–0.95) | 0.02 |
| Tumour location | ||||
| Not on the head | 1.00 | 0.86 | ||
| On the head | 0.90 (0.25–3.18) | |||
| Tumour subtype | ||||
| Non-infiltrative | 1.00 | 0.16 | 1.00 | 0.06 |
| Infiltrative | 0.46 (0.16–1.35) | 0.21 (0.04–1.08) | ||
| Bone invasion | ||||
| No | 1.00 | 0.67 | ||
| Yes | 0.78 (0.25–2.46) | |||
| Previous therapy | ||||
| No | 1.00 | 0.44 | 1.00 | 0.22 |
| Yes | 0.44 (0.24–1.86) | 0.46 (0.13–1.58) | ||
| Previous radiotherapy | ||||
| No | 1.00 | 0.61 | ||
| Yes | 1.40 (0.39–5.06) | |||
| Participant in trial | ||||
| No | 1.00 | 0.09 | 1.00 | <0.01 |
| Yes | 2.38 (0.86–6.58) | 10.08 (2.14–47.43) | ||
HRs for complete response with 95% CI in patients with laBCC.
HR > 1 and HR < 1 indicate increased and decreased probability of response, respectively, where categories with HR = 1 were used as the reference category. P < 0.05 is considered statistically significant.
HRs hazard ratios, 95% CI 95% confidence interval.
aThe HR for age represents the increase in probability per year.
bThe HR for tumour size represents the increase in probability per cm.